Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Crossignal Therapeutics, Inc.

Clinical trials sponsored by Crossignal Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New hope for Hard-to-Treat cancers? early trial launches Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New hope for Hard-to-Treat cancers? early trial launches

    Disease control Recruiting now

    This early-phase study tests a new drug called CT3001 in people with advanced solid tumors (like colorectal or pancreatic cancer) that have stopped responding to standard treatments. The study has two parts: first, finding a safe dose of CT3001 alone, then testing it combined wit…

    Phase 1/2 • Sponsor: Crossignal Therapeutics, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 13:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space